Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delafloxacin vs Tigecycline in Complicated Skin and Skin Structure Infections
NCT00719810Phase 2Completed
- Sponsor
- Melinta Therapeutics
- Start
- Jun 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of delafloxacin in Skin and Skin Structure Infection (SSSI), sponsored by Melinta Therapeutics. Started Jun 2008; status: completed.
02
Drugs
delafloxacin
03
Conditions
Skin and Skin Structure Infection (SSSI)
Beyond the preview
Go deeper on NCT00719810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00719810.